Quantcast

Latest Fluticasone/salmeterol Stories

2009-06-23 07:00:00

Emerging Combination Products from GlaxoSmithKline/Theravance, Boehringer Ingelheim and Novartis Will Drive Growth, According to a New Report from Decision Resources WALTHAM, Mass., June 23 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a 28 percent increase in the diagnosed prevalent population will drive growth in the chronic obstructive pulmonary disease (COPD) drug market in the United...

2009-06-01 07:00:00

Most Influential COPD Brand Messages Are Those That Highlight Maintenance of Daily Activities, Ease of Breathing and Reduction of Symptoms Decision Resources Introduces New Brand Perception Series WALTHAM, Mass., June 1 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that surveyed pulmonologists and patients view Boehringer Ingelheim/Pfizer's Spiriva as the best and second-best chronic...

2009-02-10 09:01:27

Newly published research out of Wake Forest University School of Medicine finds that a popular class of anti-inflammatory inhalers significantly increases the risk of pneumonia in patients with Chronic Obstructive Pulmonary Disease (COPD).The study appears in this month's issue of Archives of Internal Medicine and focuses on the incidence of pneumonia in patients with COPD who were exposed to inhaled corticosteroid drugs, either alone or in combination with other drugs.COPD is a progressive...

2008-12-22 12:15:00

JEFFERSON, N.C., Dec. 22 /PRNewswire/ -- Next Safety has developed a proprietary platform that delivers nicotine and a number of other drugs including albuterol and the components of Advair(TM), fluticasone propionate and salmeterol xinofoate, in air timed to the user's inhalation. Certain US patents for the chemical components of Advair(TM) expired September 2008. Next Safety's platform has numerous advantages over current methods used for delivering these significant asthma...

2008-12-15 12:20:00

JEFFERSON, N.C., Dec. 15 /PRNewswire/ -- Inhalers used for delivering albuterol, a fast-acting bronchial dilator, currently use propellants such as ozone-depleting CFC's, which are banned by the FDA beginning December 31st, 2009, or replacement HFA's. Both propellants are also used as industrial refrigerants and eject the medicine, albuterol, at near-supersonic speeds. The Next Safety device supplies medication in a stream of air by ejecting the medication from a microfluidic pump...

2008-12-12 05:12:52

A U.S. Food and Drug Administration panel said the drugs Serevent and Foradil shouldn't be used for treating asthma. The panel said Serevent and Foradil are often prescribed inappropriately by doctors and used incorrectly by patients, The New York Times said Thursday. The drugs are longer-acting beta agonists intended to prevent attacks but have been shown to increase the risk of more severe attacks if used without a steroid, the newspaper said. The panel ruled that Advair and Symbicort...

2008-12-11 16:04:00

WASHINGTON, Dec. 11 /PRNewswire-FirstCall/ -- The following is GlaxoSmithKline's (NYSE: GSK) statement regarding recommendations of a combined Advisory Committee to the FDA on the use of asthma medicines containing long-acting beta agonists, including GSK's Serevent(R) (salmeterol) and Advair(R) (salmeterol/fluticasone proprionate). "We welcome the committee's endorsement of Advair as a safe and effective treatment for asthma in adults and children," said Dr. Ellen Strahlman, Chief...

2008-12-10 13:07:00

MENLO PARK, Calif., Dec. 10 /PRNewswire/ -- As part of the broader public discussion around asthma sparked by the FDA's examination of the commonly prescribed asthma drugs Advair, Symbicort, Serevent and Foradil, Dr. Philip Marcus, Chief, Division of Pulmonary Medicine, St. Francis Hospital, and Dr. James Wolfe, of Allergist, Allergy and Asthma Associates of Northern California, are available to discuss exhaled nitric oxide monitoring as an essential addition to asthma treatment,...

d9cbf5228b14efb44c88ae5aa9bdfd0b1
2008-12-10 10:47:21

Recently, millions of asthma patients have begun taking long-acting drugs to allow them to breathe a bit more normally, which allow them to experience continual sleep in the evenings or workouts at the gym. At the moment, the Food and Drug Administration is examining if these medications could increase the risk of severe asthma problems. At a meeting on Wednesday, independent medical advisers will review the scientific facts and make a decision on if the drugs should continue to be used in...

2008-12-01 07:00:00

WALTHAM, Mass., Dec. 1 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that patient share for GlaxoSmithKline's Advair is declining in all lines of therapy for newly diagnosed asthma patients. The new report entitled Treatment Algorithms in Asthma shows a reduction in Advair use in first-, second- and third-lines of therapy to 12.2 percent, 13.6 percent, and 14.6 percent, respectively...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related